Research of the epidemiology on cancer of the trachea, bronchi, lungs as important components in the development of effective directions for increasing the effectiveness of pharmaceutical support for cancer patients

Authors

DOI:

https://doi.org/10.15587/2519-4852.2021.230346

Keywords:

National Cancer Registry, oncoepidemiology, oncoepidemiological profile of the population of Ukraine, cancer of the trachea, bronchi and lungs, pharmaceutical provision of cancer patients

Abstract

The aim: to conduct epidemiological studies on cancer of the trachea, bronchi, lungs as important components in the development of effective directions for increasing the effectiveness of pharmaceutical support for cancer patients in Ukraine.

Materials and methods. The study used data from special literature, which presents the results of research on cancer in different countries of the world and data from the National Cancer Registry from 2014-2019 by indicators of morbidity and mortality of the population of Ukraine from cancer of the trachea, bronchi and lungs, including by gender. General theoretical (historical, analytical-comparative, systemic, graphic, logical, hypothetical-deductive) and applied (mathematical-statistical, epidemiological) research methods were used.

Results. It was found that during 2014-2018 in terms of morbidity and mortality of the population from cancer of the trachea, bronchi and lungs in Ukraine, there was a positive dynamics of decline. So, in terms of incidence rates, which are standardized by WHO in 2018, the data decreased compared to 2014 by 8.4 %, and according to the “Ukrainian standard” – by 7.0 %. Mortality rates, which were standardized by WHO, decreased in 2018 compared to 2014 by 12.1 %, and those presented according to the “Ukrainian standard” – by 11.1 %. It was proved that the average data on morbidity and mortality of male patients were 6.2 and 7.4 times higher than in the same data for female patients. The different nature of changes in morbidity and mortality rates of patients in accordance with their gender in the dynamics of years has been established. So, for the female cohort of patients, the incidence and mortality rate from cancer of the trachea, bronchi and lungs during 2014-2018 had a complex zigzag character of changes, and in 2019, compared with the data of 2014, they increased by 22.54 % and 23.6 %, respectively. In the male cohort of patients, we observed a positive trend towards a decrease in mortality during 2014-2019. So, in 2019, these indicators reached their minimum and were equal to 57.0 and 44.0 cases per 100 thousand population. According to the data of 2019, the incidence and mortality of men from cancer of the trachea, bronchi and lungs relative to the data of 2014 decreased by 21.4 % and 25.0 %, respectively. It looks encouraging that there was relatively little fluctuation during 2014-2019 epidemiological indicators, both in general for the entire population of patients and female patients.

Conclusions. The established characteristics and trends in the formation of the onco-epidemiological profile of the country's population for trachea, bronchus and lung cancer in dynamics over the years necessitate further research, taking into account changes in the main demographic indicators development of society

Author Biographies

Yurii Pulnyi, National University of Pharmacy

Postgraduate Student

Department of Organization and Economics of Pharmacy

Hanna Panfilova, National University of Pharmacy

Doctor of Pharmaceutical Sciences, Professor

Department of Organization and Economics of Pharmacy

Ellona Shelkova, Center for Professional Harmonization "Reforma ZOZ"

PhD, Leading Consultant on Evidence-Based Medicine, Director of Center

Oleksandr Kabachnyi , Center for Professional Harmonization "Reforma ZOZ"

PhD, Leading Consultant on Evidence-Based Medicine

Vitaly Chernukha, National University of Pharmacy

PhD, Associate Professor

Department of Organization and Economics of Pharmacy

References

  1. Khajedaluee, M., Dadgarmoghaddam, M., Saeedi, R., Izadi-Mood, Z., Abrishami, M., Zamani, M. (2014). Mortality, Morbidity, Survival, and Burden of Top 9 Cancers in a Developing Country. Razavi International Journal of Medicine, 2(3). doi: http://doi.org/10.5812/rijm.20073
  2. Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H. et. al. (2013). Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer, 49 (6), 1374–1403. doi: http://doi.org/10.1016/j.ejca.2012.12.027
  3. WHO. Cancer. Key Facts. Available at: https://www.who.int/news-room/fact-sheets/detail/cancer Last accessed: 15.03.2021
  4. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68 (6), 394–424. doi: http://doi.org/10.3322/caac.21492
  5. Fang, J.-Y., Dong, H.-L., Wu, K.-S., Du, P.-L., Xu, Z.-X., Lin, K. (2015). Characteristics and Prediction of Lung Cancer Mortality in China from 1991 to 2013. Asian Pacific Journal of Cancer Prevention, 16 (14), 5829–5834. doi: http://doi.org/10.7314/apjcp.2015.16.14.5829
  6. Brenner, D. R., Boffetta, P., Duell, E. J., Bickeboller, H., Rosenberger, A., McCormack, V. et. al. (2012). Previous Lung Diseases and Lung Cancer Risk: A Pooled Analysis From the International Lung Cancer Consortium. American Journal of Epidemiology, 176 (7), 573–585. doi: http://doi.org/10.1093/aje/kws151
  7. Hüsing, A., Kaaks, R. (2020). Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data. European Journal of Epidemiology, 35 (10), 899–912. doi: http://doi.org/10.1007/s10654-020-00657-w
  8. Gray, E. P., Teare, M. D., Stevens, J., Archer, R. (2016). Risk Prediction Models for Lung Cancer: A Systematic Review. Clinical Lung Cancer, 17 (2), 95–106. doi: http://doi.org/10.1016/j.cllc.2015.11.007
  9. Becker, N., Motsch, E., Gross, M.-L., Eigentopf, A., Heussel, C. P., Dienemann, H. et. al. (2015). Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization. Journal of Thoracic Oncology, 10 (6), 890–896. doi: http://doi.org/10.1097/jto.0000000000000530
  10. De Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A. et. al. (2020). Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. New England Journal of Medicine, 382 (6), 503–513. doi: http://doi.org/10.1056/nejmoa1911793
  11. Zhong, Y. J., Wen, Y. F., Wong, H. M., Yin, G., Lin, R., Yang, S. Y. (2019). Trends and Patterns of Disparities in Burden of Lung Cancer in the United States, 1974-2015. Frontiers in Oncology, 9. doi: http://doi.org/10.3389/fonc.2019.00404
  12. Albreht, T., Martin-Moreno, J. M., Jelenc, M., Gorgojo, L., Harris, M. (Eds.) (2015). European Guide for Quality National Cancer Control Programme. Ljubljana, 113.
  13. Thun, M. J., Carter, B. D., Feskanich, D., Freedman, N. D., Prentice, R., Lopez, A. D. et. al. (2013). 50-Year Trends in Smoking-Related Mortality in the United States. New England Journal of Medicine, 368 (4), 351–364. doi: http://doi.org/10.1056/nejmsa1211127
  14. Ferreccio, C., Yuan, Y., Calle, J., Benítez, H., Parra, R. L., Acevedo, J. et. al. (2013). Arsenic, Tobacco Smoke, and Occupation. Epidemiology, 24 (6), 898–905. doi: http://doi.org/10.1097/ede.0b013e31829e3e03
  15. Torre, L. A., Siegel, R. L., Ward, E. M., Jemal, A. (2014). International Variation in Lung Cancer Mortality Rates and Trends among Women. Cancer Epidemiology Biomarkers & Prevention, 23 (6), 1025–1036. doi: http://doi.org/10.1158/1055-9965.epi-13-1220
  16. Chien, L.-H., Chen, C.-H., Chen, T.-Y., Chang, G.-C., Tsai, Y.-H., Hsiao, C.-F. et. al. (2019). Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model. Cancer Epidemiology Biomarkers & Prevention, 29 (2), 452–459. doi: http://doi.org/10.1158/1055-9965.epi-19-1221
  17. Nakamura, H., Ando, K., Shinmyo, T., Morita, K., Mochizuki, A., Kurimoto, N., Tatsunami, S. (2011). Female Gender Is an Independent Prognostic Factor in Non-small-cell Lung Cancer: A Meta-analysis. Annals of Thoracic and Cardiovascular Surgery, 17 (5), 469–480. doi: http://doi.org/10.5761/atcs.oa.10.01637
  18. De Torres, J. P., Marín, J. M., Casanova, C., Cote, C., Carrizo, S., Cordoba-Lanus, E. et. al. (2011). Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 184 (8), 913–919. doi: http://doi.org/10.1164/rccm.201103-0430oc
  19. Infante, M., Cavuto, S., Lutman, F. R., Passera, E., Chiarenza, M., Chiesa, G. et. al. (2015). Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. American Journal of Respiratory and Critical Care Medicine, 191 (10), 1166–1175. doi: http://doi.org/10.1164/rccm.201408-1475oc
  20. Yang, D., Liu, Y., Bai, C., Wang, X., Powell, C. A. (2020). Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Letters, 468, 82–87. doi: http://doi.org/10.1016/j.canlet.2019.10.009
  21. Hamra, G. B., Guha, N., Cohen, A., Laden, F., Raaschou-Nielsen, O., Samet, J. M. et. al. (2014). Outdoor Particulate Matter Exposure and Lung Cancer: A Systematic Review and Meta-Analysis. Environmental Health Perspectives, 122 (9), 906–911. doi: http://doi.org/10.1289/ehp/1408092
  22. Raaschou-Nielsen, O., Andersen, Z. J., Beelen, R., Samoli, E., Stafoggia, M., Weinmayr, G. et. al. (2013). Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). The Lancet Oncology, 14 (9), 813–822. doi: http://doi.org/10.1016/s1470-2045(13)70279-1
  23. Vermeulen, R., Silverman, D. T., Garshick, E., Vlaanderen, J., Portengen, L., Steenland, K. (2014). Exposure-Response Estimates for Diesel Engine Exhaust and Lung Cancer Mortality Based on Data from Three Occupational Cohorts. Environmental Health Perspectives, 122 (2), 172–177. doi: http://doi.org/10.1289/ehp.1306880
  24. National Cancer Registry of Ukraine: short description of the database (2020). Cancer in Ukraine 2018–2019. Available at: http://www.ncru.inf.ua/publications/
  25. Fang, J.-Q. (Ed.) (2017). Handbook of Medical Statistics. Sun Yat-Sen University, 852. doi: http://doi.org/10.1142/10259
  26. Barta, J. A., Powell, C. A., Wisnivesky, J. P. (2019). Global Epidemiology of Lung Cancer. Annals of Global Health, 8 5(1). doi: http://doi.org/10.5334/aogh.2419
  27. Jemal, A., Bray, F., Forman, D., O’Brien, M., Ferlay, J., Center, M., & Parkin, D. M. (2012). Cancer burden in Africa and opportunities for prevention. Cancer, 118 (18), 4372–4384. doi: http://doi.org/10.1002/cncr.27410
  28. Shushpanov, D. G. (2016). Causes and determinants of ultrahigh mortality in Ukraine: comparative social and demographic analysis with the European Union countries. Economic analysis, 23 (1), 111–122.
  29. De Groot, P. M., Wu, C. C., Carter, B. W., Munden, R. F. (2018). The epidemiology of lung cancer. Translational Lung Cancer Research, 7 (3), 220–233. doi: http://doi.org/10.21037/tlcr.2018.05.06
  30. Zheng, W., Zhang, H., Shen, C., Zhang, S., Wang, D., Li, W., Jiang, G. (2020). Trend analysis of lung cancer mortality and years of life lost (YLL) rate from 1999 to 2016 in Tianjin, China: Does the lung cancer burden in rural areas exceed that of urban areas? Thoracic Cancer, 11 (4), 867–874. doi: http://doi.org/10.1111/1759-7714.13314
  31. Liang, F., Wu, C., Gu, H., Zhu, M., Xuan, Z., Jiang, Y. et. al. (2019). Lung cancer incidence in female rises significantly in urban sprawl of Shanghai after introduction of LDCT screening. Lung Cancer, 132, 114–118. doi: http://doi.org/10.1016/j.lungcan.2019.04.020
  32. Lebed, O. O., Trusheva, S. S., Lysytsya, A. V. (2019). Impact of radon exposure upon dynamics of mortality rate from lung cancer for population of Rivne city, Ukraine. Ukrainian Journal of Ecology, 9 (1), 25–34.
  33. Shvaiko, L., Sushko, V., Bazyka, K. (2013). Lung cancer cases in clean-up workers of Chernobyl NPP accident. European Respiratory Journal, 42 (5742), 4503. Available at: https://erj.ersjournals.com/content/42/Suppl_57/P4503.article-info Last accessed: 15.02.2021
  34. Islami, F., Torre, L. A., Jemal, A. (2015). Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res, 4 (4), 327–338.
  35. Siegel, R. L., Miller, K. D., Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70 (1), 7–30. doi: http://doi.org/10.3322/caac.21590
  36. Yang, J., Zhu, J., Zhang, Y.-H., Chen, Y.-S., Ding, L.-L., Kensler, T. W., Chen, J.-G. (2015). Lung Cancer in a Rural Area of China: Rapid Rise in Incidence and Poor Improvement in Survival. Asian Pacific Journal of Cancer Prevention, 16 (16), 7295–7302. doi: http://doi.org/10.7314/apjcp.2015.16.16.7295
  37. Pinsky, P. F., Church, T. R., Izmirlian, G., Kramer, B. S. (2013). The National Lung Screening Trial: Results stratified by demographics, smoking history, and lung cancer histology. Cancer, 119 (22), 3976–3983. doi: http://doi.org/10.1002/cncr.28326

Downloads

Published

2021-04-30

How to Cite

Pulnyi, Y., Panfilova, H., Shelkova, E., Kabachnyi , O., & Chernukha, V. (2021). Research of the epidemiology on cancer of the trachea, bronchi, lungs as important components in the development of effective directions for increasing the effectiveness of pharmaceutical support for cancer patients . ScienceRise: Pharmaceutical Science, (2 (30), 72–80. https://doi.org/10.15587/2519-4852.2021.230346

Issue

No. 2 (30) (2021)

Section

Pharmaceutical Science

License

Copyright (c) 2021 Yurii Pulnyi, Hanna Panfilova, Ellona Shelkova, Oleksandr Kabachnyi , Vitaly Chernukha

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.